Stay updated on Dupilumab Efficacy in Persistent Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Persistent Asthma Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Persistent Asthma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check17 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.4%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%
- Check39 days agoChange DetectedThe page has updated the citation for a study on Dupilumab efficacy and safety in patients with persistent asthma, reflecting a new version and a change in publication date.SummaryDifference0.6%
- Check46 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with a list of publications related to dupilumab, while removing several outdated terms and categories related to drugs and locations.SummaryDifference5%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Dupilumab Efficacy in Persistent Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Persistent Asthma Clinical Trial page.